ClinicalTrials.gg
CompletedNCT01544933Updated Mar 6, 2012

The Influence of the Ribs on the Gravity of Burst Thoracic Spine Fractures

An observational study in Burst Thoracic Spine Fractures, sponsored by Universidade de Passo Fundo. Completed at 1 site in Brazil. Open to participants aged 17 Years to 79 Years. Per ClinicalTrials.gov, last updated 2012-03-06.

Sponsored by Universidade de Passo Fundo · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
2
Ages
17 Years to 79 Years
Sex
All
01

Study summary

The purpose of this study is to analyse the anatomic influence of the ribs related to the incidence and severity of burst spine fractures.

Read the detailed description

To analyse the anatomic influence of the ribs related to the incidence and severity of burst spine fractures, with the measurements of kyphosis, vertebral collapse and vertebral canal narrowing

02

Conditions studied

  • Burst Thoracic Spine Fractures

Keywords

  • spinal fractures
  • Thoracic vertebrae
  • spinal canal
  • kyphosis
03

In context

Spinal Fractures

167 studies on the registry are indexed under Spinal Fractures; 29 are open to participants now.

This study's enrollment of 2 is below the median of 130 across 58 observational studies indexed under Spinal Fractures.

Browse Spinal Fractures studies →

Lead sponsor

Universidade de Passo Fundo is the lead sponsor of 15 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients with burst fractures of the thoracic spine treated by the Hospital Ortopedico de Passo Fundo

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • burst fractures in thoracic spine

Exclusion criteria

Exclusion Criteria:

  • fractures that were not burst fractures in thoracic spine
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
2 participants (actual)

Groups and cohorts

  • burst fractures in vertebrae with true ribs

    between T1 and T10

  • burst fractures in vertebrae with floating ribs

    between T11 and T12

06

What researchers measure

Primary outcomes

  1. residual kyphosis

    measurement of residual kyphosis by x-ray

    Time frame: 3 years

Secondary outcomes

  1. vertebral canal narrowing

    vertebral canal narrowing in CT

    Time frame: 3 years

07

Study locations

1 site
  • Rodrigo Tisot
    Passo Fundo, Rio Grande do Sul 99010-121, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01544933
Lead sponsor
Universidade de Passo Fundo
Responsible party
Rodrigo Arnold Tisot (Principal investigator, Universidade de Passo Fundo) — Principal investigator
First posted
Mar 6, 2012
Start date
Feb 2011
Primary completion
Aug 2011
Completion
Sep 2011
Last update
Mar 6, 2012

Study contacts

Rodrigo A Tisot, Dr
study director · Hospital Ortopedico de Passo Fundo

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion